These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30126448)

  • 1. A randomized placebo controlled clinical trial to evaluate the efficacy and safety of minocycline in patients with Angelman syndrome (A-MANECE study).
    Ruiz-Antoran B; Sancho-López A; Cazorla-Calleja R; López-Pájaro LF; Leiva Á; Iglesias-Escalera G; Marín-Serrano ME; Rincón-Ortega M; Lara-Herguedas J; Rossignoli-Palomeque T; Valiente-Rodríguez S; González-Marques J; Román-Riechmann E; Avendaño-Solá C
    Orphanet J Rare Dis; 2018 Aug; 13(1):144. PubMed ID: 30126448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome.
    Leigh MJ; Nguyen DV; Mu Y; Winarni TI; Schneider A; Chechi T; Polussa J; Doucet P; Tassone F; Rivera SM; Hessl D; Hagerman RJ
    J Dev Behav Pediatr; 2013 Apr; 34(3):147-55. PubMed ID: 23572165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label pilot trial of minocycline in children as a treatment for Angelman syndrome.
    Grieco JC; Ciarlone SL; Gieron-Korthals M; Schoenberg MR; Smith AG; Philpot RM; Heussler HS; Banko JL; Weeber EJ
    BMC Neurol; 2014 Dec; 14():232. PubMed ID: 25491305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol.
    Qurashi I; Chaudhry IB; Khoso AB; Farooque S; Lane S; Husain MO; Chu S; Sarginson J; Hamarani M; Naqvi HA; Razzaque B; Minhas FA; Yung AR; Deakin JFW; Husain N
    Trials; 2017 Nov; 18(1):524. PubMed ID: 29121974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial.
    Emadi-Kouchak H; Mohammadinejad P; Asadollahi-Amin A; Rasoulinejad M; Zeinoddini A; Yalda A; Akhondzadeh S
    Int Clin Psychopharmacol; 2016 Jan; 31(1):20-6. PubMed ID: 26465919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.
    Tilley BC; Alarcón GS; Heyse SP; Trentham DE; Neuner R; Kaplan DA; Clegg DO; Leisen JC; Buckley L; Cooper SM; Duncan H; Pillemer SR; Tuttleman M; Fowler SE
    Ann Intern Med; 1995 Jan; 122(2):81-9. PubMed ID: 7993000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: a double blind, randomized, controlled trial.
    Liu F; Guo X; Wu R; Ou J; Zheng Y; Zhang B; Xie L; Zhang L; Yang L; Yang S; Yang J; Ruan Y; Zeng Y; Xu X; Zhao J
    Schizophr Res; 2014 Mar; 153(1-3):169-76. PubMed ID: 24503176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial.
    Howard R; Zubko O; Bradley R; Harper E; Pank L; O'Brien J; Fox C; Tabet N; Livingston G; Bentham P; McShane R; Burns A; Ritchie C; Reeves S; Lovestone S; Ballard C; Noble W; Nilforooshan R; Wilcock G; Gray R;
    JAMA Neurol; 2020 Feb; 77(2):164-174. PubMed ID: 31738372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of minocycline on lumbar radicular neuropathic pain: a randomized, placebo-controlled, double-blind clinical trial with amitriptyline as a comparator.
    Vanelderen P; Van Zundert J; Kozicz T; Puylaert M; De Vooght P; Mestrum R; Heylen R; Roubos E; Vissers K
    Anesthesiology; 2015 Feb; 122(2):399-406. PubMed ID: 25373391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial.
    Fekadu A; Mesfin M; Medhin G; Alem A; Teferra S; Gebre-Eyesus T; Seboxa T; Assefa A; Hussein J; Lemma MT; Borba C; Henderson DC; Hanlon C; Shibre T
    Trials; 2013 Nov; 14():406. PubMed ID: 24279305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial.
    Ghaleiha A; Alikhani R; Kazemi MR; Mohammadi MR; Mohammadinejad P; Zeinoddini A; Hamedi M; Shahriari M; Keshavarzi Z; Akhondzadeh S
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):784-791. PubMed ID: 27128958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.
    Casha S; Zygun D; McGowan MD; Bains I; Yong VW; Hurlbert RJ
    Brain; 2012 Apr; 135(Pt 4):1224-36. PubMed ID: 22505632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial.
    Grainger JD; Locatelli F; Chotsampancharoen T; Donyush E; Pongtanakul B; Komvilaisak P; Sosothikul D; Drelichman G; Sirachainan N; Holzhauer S; Lebedev V; Lemons R; Pospisilova D; Ramenghi U; Bussel JB; Bakshi KK; Iyengar M; Chan GW; Chagin KD; Theodore D; Marcello LM; Bailey CK
    Lancet; 2015 Oct; 386(10004):1649-58. PubMed ID: 26231455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 study.
    Keary C; Bird LM; de Wit MC; Hatti S; Heimer G; Heussler H; Kolevzon A; Mathews A; Ochoa-Lubinoff C; Tan WH; Yan Y; Adams M
    Eur J Paediatr Neurol; 2023 Nov; 47():6-12. PubMed ID: 37639777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis.
    Metz LM; Li DKB; Traboulsee AL; Duquette P; Eliasziw M; Cerchiaro G; Greenfield J; Riddehough A; Yeung M; Kremenchutzky M; Vorobeychik G; Freedman MS; Bhan V; Blevins G; Marriott JJ; Grand'Maison F; Lee L; Thibault M; Hill MD; Yong VW;
    N Engl J Med; 2017 Jun; 376(22):2122-2133. PubMed ID: 28564557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.
    Gordon PH; Moore DH; Miller RG; Florence JM; Verheijde JL; Doorish C; Hilton JF; Spitalny GM; MacArthur RB; Mitsumoto H; Neville HE; Boylan K; Mozaffar T; Belsh JM; Ravits J; Bedlack RS; Graves MC; McCluskey LF; Barohn RJ; Tandan R;
    Lancet Neurol; 2007 Dec; 6(12):1045-53. PubMed ID: 17980667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome.
    Bird LM; Ochoa-Lubinoff C; Tan WH; Heimer G; Melmed RD; Rakhit A; Visootsak J; During MJ; Holcroft C; Burdine RD; Kolevzon A; Thibert RL
    Neurology; 2021 Feb; 96(7):e1024-e1035. PubMed ID: 33443117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.